Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lumiradx Ltd
(NQ:
LMDX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lumiradx Ltd
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8...
Via
Benzinga
Surging Omicron-Related Cases Lift LumiraDx Q4 Sales, Expects Sequentially Flat Q1 FY22 Sales
March 10, 2022
LumiraDx Limited's (NASDAQ: LMDX) Q4 FY21 sales increased 5.3% Y/Y to $118.3 million, surpassing the consensus of $69.6 million. SARS-CoV-2 Antigen test strips...
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 28, 2022
Gainers Provention Bio (NASDAQ:PRVB) stoc...
Via
Benzinga
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
January 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel Pharma Starts Phase 1/2 Blood Cancer Study Corvus...
Via
Benzinga
Why Are LumiraDx Shares Trading Higher Today?
October 20, 2021
LumiraDx (NASDAQ:LMDX) has
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 01, 2022
During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a...
Via
Benzinga
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
52 Biggest Movers From Yesterday
February 15, 2022
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences...
Via
Benzinga
FDA Reissues Emergency Use Authorization For LumiraDx's COVID-19 Testing Solution
December 01, 2021
The FDA has reissued Emergency Use Authorization (EUA) to LumiraDx Ltd's (NASDAQ: LMDX) SARS-CoV-2 RNA STAR Complete, a rapid nucleic acid amplification...
Via
Benzinga
Exposures
COVID-19
Product Safety
Earnings Scheduled For November 10, 2021
November 10, 2021
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million. • IsoPlexis (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
November 15, 2021
Upgrades For Targa Resources Corp (NYSE:
Via
Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For October 25, 2021
October 25, 2021
Upgrades According to Wedbush, the prior rating for Regions Financial Corp (NYSE:
Via
Benzinga
26 Stocks Moving in Friday's Pre-Market Session
October 22, 2021
Gainers Phunware, Inc. (NASDAQ: PHUN) rose 300% to $6.10 in pre-market trading. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition...
Via
Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19...
Via
Benzinga
The Week In SPAC News - Sunday, Oct. 3
October 03, 2021
In SPAC news this week, Amicus Therapeutics announced its intent to sell its gene therapy unit to ARYA Sciences Acquisition Corp IV, a SPAC sponsored by Perceptive Advisors.
Via
Talk Markets
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...
Via
Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.
September 28, 2021
From
CA Healthcare Acquisition Corp.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.